Juanita Dionne Jackson

Array ( [id] => 2222315 [patent_doc_number] => 04582846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-04-15 [patent_title] => 'Fungicidally active novel substituted azolylethyl oximinoalkyl ethers' [patent_app_type] => 1 [patent_app_number] => 6/622438 [patent_app_country] => US [patent_app_date] => 1984-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4611 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/582/04582846.pdf [firstpage_image] =>[orig_patent_app_number] => 622438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2255229 [patent_doc_number] => 04590215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-05-20 [patent_title] => 'Growth inhibitor for cariogenic bacteria' [patent_app_type] => 1 [patent_app_number] => 6/622598 [patent_app_country] => US [patent_app_date] => 1984-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1573 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/590/04590215.pdf [firstpage_image] =>[orig_patent_app_number] => 622598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2255163 [patent_doc_number] => 04588586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-05-13 [patent_title] => 'Method for disinfecting a contact lens' [patent_app_type] => 1 [patent_app_number] => 6/621792 [patent_app_country] => US [patent_app_date] => 1984-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4324 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/588/04588586.pdf [firstpage_image] =>[orig_patent_app_number] => 621792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2220542 [patent_doc_number] => 04578403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-03-25 [patent_title] => 'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents' [patent_app_type] => 1 [patent_app_number] => 6/619184 [patent_app_country] => US [patent_app_date] => 1984-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3243 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/578/04578403.pdf [firstpage_image] =>[orig_patent_app_number] => 619184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2147120 [patent_doc_number] => 04559359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-12-17 [patent_title] => 'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents' [patent_app_type] => 1 [patent_app_number] => 6/615024 [patent_app_country] => US [patent_app_date] => 1984-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3706 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/559/04559359.pdf [firstpage_image] =>[orig_patent_app_number] => 615024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2221993 [patent_doc_number] => 04582824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-04-15 [patent_title] => 'Method for inhibiting activities of platelet activating factor' [patent_app_type] => 1 [patent_app_number] => 6/614024 [patent_app_country] => US [patent_app_date] => 1984-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8218 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/582/04582824.pdf [firstpage_image] =>[orig_patent_app_number] => 614024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2270378 [patent_doc_number] => 04584299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-04-22 [patent_title] => 'Method of treating heart failure and medicaments therefor' [patent_app_type] => 1 [patent_app_number] => 6/612275 [patent_app_country] => US [patent_app_date] => 1984-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4835 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/584/04584299.pdf [firstpage_image] =>[orig_patent_app_number] => 612275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2178426 [patent_doc_number] => 04558066 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-12-10 [patent_title] => 'Treatment and prevention of ocular hypertension' [patent_app_type] => 1 [patent_app_number] => 6/611245 [patent_app_country] => US [patent_app_date] => 1984-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12107 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/558/04558066.pdf [firstpage_image] =>[orig_patent_app_number] => 611245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2236931 [patent_doc_number] => 04572915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-02-25 [patent_title] => 'Clear micellized solutions of fat soluble essential nutrients' [patent_app_type] => 1 [patent_app_number] => 6/605797 [patent_app_country] => US [patent_app_date] => 1984-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3819 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/572/04572915.pdf [firstpage_image] =>[orig_patent_app_number] => 605797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2220484 [patent_doc_number] => 04578399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-03-25 [patent_title] => 'Use of the diterpene derivative forskolin for immunostimulation' [patent_app_type] => 1 [patent_app_number] => 6/603347 [patent_app_country] => US [patent_app_date] => 1984-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2325 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/578/04578399.pdf [firstpage_image] =>[orig_patent_app_number] => 603347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2134914 [patent_doc_number] => 04551459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-11-05 [patent_title] => 'Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides' [patent_app_type] => 1 [patent_app_number] => 6/599858 [patent_app_country] => US [patent_app_date] => 1984-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23542 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/551/04551459.pdf [firstpage_image] =>[orig_patent_app_number] => 599858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2263848 [patent_doc_number] => 04579867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-04-01 [patent_title] => 'Stable pharmaceutical compositions of short-acting .beta.-adrenergic receptor blocking agents' [patent_app_type] => 1 [patent_app_number] => 6/598131 [patent_app_country] => US [patent_app_date] => 1984-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 7324 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/579/04579867.pdf [firstpage_image] =>[orig_patent_app_number] => 598131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2157590 [patent_doc_number] => 04525341 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-06-25 [patent_title] => 'Method of administering vitamins' [patent_app_type] => 1 [patent_app_number] => 6/598480 [patent_app_country] => US [patent_app_date] => 1984-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1715 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/525/04525341.pdf [firstpage_image] =>[orig_patent_app_number] => 598480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2160065 [patent_doc_number] => 04554288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-11-19 [patent_title] => 'Use of bendazac and its salts in the treatment of retinitis pigmentosa' [patent_app_type] => 1 [patent_app_number] => 6/597504 [patent_app_country] => US [patent_app_date] => 1984-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1062 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/554/04554288.pdf [firstpage_image] =>[orig_patent_app_number] => 597504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2127756 [patent_doc_number] => 04490379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1984-12-25 [patent_title] => 'Method of reducing intraocular pressure and treating glaucoma using corynanthine' [patent_app_type] => 1 [patent_app_number] => 6/596533 [patent_app_country] => US [patent_app_date] => 1984-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3957 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/490/04490379.pdf [firstpage_image] =>[orig_patent_app_number] => 596533 [rel_patent_id] =>[rel_patent_doc_number] =>)